TNFR2/CD120b/TNFRSF1B, His, Human
| ¥2600 | |
| Z05895-100 | |
|
|
|
|
|
|
|
|
|
| ¥2600 | |
| Z05895-100 | |
|
|
|
|
|
|
|
|
|
| Species | Human | ||||
| Protein Construction |
|
||||
| Purity | > 95% as determined by BisTris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Biological Activity | Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 26.2 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 48-60 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Immobilized TNFR2/CD120b/TNFRSF1B, His, Human, His Tag at 5 μg/ml (100 μl/well) on the plate. Dose response curve for Biotinylated Human TNF alpha, His Tag with the EC50 of 16.0ng/ml determined by ELISA. »
Immobilized TNFR2/CD120b/TNFRSF1B, His, Human at 0.5 μg/ml(100 μl/well) on the plate. Dose response curve for Anti-TNFR2 Antibody, hFc Tag with the EC50 of 6.4ng/ml determined by ELISA. »
The purity of TNFR2/CD120b/TNFRSF1B, His, Human is greater than 95% as determined by SEC-HPLC. »
TNFR2/CD120b/TNFRSF1B, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | Tumor Necrosis Factor Receptor II (TNF RII), also known as TNFRSF1B, p75/p80, and CD120b, is a type I transmembrane protein that belongs to the TNF receptor superfamily. It has a molecular weight of approximately 75 kDa.Receptor with high affinity for TNFSF2/TNF-alpha and approximately 5-fold lower affinity for homotrimeric TNFSF1/lymphotoxin-alpha. The TRAF1/TRAF2 complex recruits the apoptotic suppressors BIRC2 and BIRC3 to TNFRSF1B/TNFR2. This receptor mediates most of the metabolic effects of TNF-alpha. Isoform 2 blocks TNF-alpha-induced apoptosis, which suggests that it regulates TNF-alpha function by antagonizing its biological activity. |
| Synonyms | CD120b; Etanercept; p75TBPII; p75TNFR; TNF RII; TNF-R2; TNF-R75; TNFR80; TNFRSF1B; TNFR2; TBPII; TNFBR; TNFR1B |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.